FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Athina Markou

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Concepts & Ideas

Activities & Behaviors

Animal Behavior

Procedures

Self Administration

Co-author Network

Publications

TOP 3
Matthias E Liechti; Athina Markou
Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.
Svetlana Semenova; Mark A Geyer; J Gregor Sutcliffe; Athina Markou; Peter B Hedlund
Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Matthias E Liechti; Athina Markou
Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Athina Markou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Matthias E Liechti; Athina Markou
Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.
CNS drugs 2008;22(9):705-24.
2008: Svetlana Semenova; Mark A Geyer; J Gregor Sutcliffe; Athina Markou; Peter B Hedlund
Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Biological psychiatry 2008;63(1):98-105.
2007: Matthias E Liechti; Athina Markou
Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.
Biochemical pharmacology 2007;74(8):1299-307.
2007: Nurith Amitai; Svetlana Semenova; Athina Markou
Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
Psychopharmacology 2007;193(4):521-37.
2007: Matthias E Liechti; Loic Lhuillier; Klemens Kaupmann; Athina Markou
Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(34):9077-85.
2007: Svetlana Semenova; Ian P Stolerman; Athina Markou
Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats.
Pharmacology, biochemistry, and behavior 2007;87(3):360-8.
2007: Athina Markou
The role of metabotropic glutamate receptors in drug reward, motivation and dependence.
Drug news & perspectives 2007;20(2):103-8.
2007: Svetlana Semenova; Athina Markou
The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task.
Neuropharmacology 2007;52(3):863-72.
2007: Matthias E Liechti; Athina Markou
Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
European journal of pharmacology 2007;554(2-3):164-74.
2007: Neil E Paterson; Athina Markou
Animal models and treatments for addiction and depression co-morbidity.
Neurotoxicity research 2007;11(1):1-32.
2002: S A Henry; V Lehmann-Masten; F Gasparini; Mark A Geyer; Athina Markou
The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.
Neuropharmacology 2002;43(8):1199-209.